Category: Disorders & Diseases

Disorders & Diseases

Latest

Brinsupri/Brensocatib Approved for Bronchiectasis in Japan

Japan's Ministry of Health, Labour and Welfare (MHLW) has approved Brinsupri (brensocatib 25-mg tablet), an oral, once-daily treatment for non-cystic fibrosis bronchiectasis (NCFB) in adults and pediatric patients 12 years and older, according to Insmed Inc.